Clement Mweya
Prostate cancer is the second most common cancer among men worldwide, with approximately 1.3 million new cases and 359,000 deaths reported in 2018 alone. The incidence of prostate cancer varies widely across regions, with higher rates observed in developed countries. The majority of cases are diagnosed in men over the age of 65, although the disease can occur at any age. Early detection of prostate cancer is essential for successful treatment outcomes. Screening tests, such as prostate-specific antigen (PSA) blood tests and digital rectal examinations (DRE), are commonly used to detect prostate cancer. However, low knowledge of prostate cancer screening and wrong perceptions about the disease can lead to poor screening practices, resulting in delayed diagnoses and poorer outcomes.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 